Precipio, Inc. (PRPO) Stock Ticker
Market factors today
Unlock the full PRPO picture
About Precipio, Inc.
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell lineages, and HemeScreen, a comprehensive collection of genetic diagnostic panels. Precipio also develops COVID-19 antibody tests. A notable proprietary innovation is ICE-COLD PCR, a patented technology designed to boost the sensitivity of molecular tests, with kits for this technology also sold to biopharmaceutical customers. Additionally, Precipio, Inc. collaborates with academic institutions dedicated to cancer research, diagnosis, and therapy.
PRPO stock facts
| Ticker symbol | PRPO |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| Market cap | $42.2M |
| CEO | Ilan Danieli |
| Employees | 61 |
| Headquarters | New Haven, CT, US |
| IPO date | 2017-06-30 |
| Website | www.precipiodx.com |
What you can see for PRPO on Tickr
Live PRPO price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PRPO report.
Rankings
FAQ
What is the ticker symbol for Precipio, Inc.?
The ticker symbol for Precipio, Inc. is PRPO, listed on the NASDAQ Capital Market.
What is PRPO?
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell…